TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21454024

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Voucher Control (VC)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Community Reinforcement Approach (CRA)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Twelve-Step Facilitation (TSF)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: All groups (including CM, VC, CRA, TSF)
Number of subjects: 145
Study: 19170452

Group type: EXPERIMENTAL
Intervention: GPI + GMET
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: GPI
Number of subjects: 484

Group type: COMPARATOR
Intervention: INFO
Number of subjects: 484
Study: 17370662

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid/polylactic acid bioresorbable membranes plus scaling and root planing (SRP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 30
Study: 15983823

Group type: EXPERIMENTAL
Intervention: Orange juice (200 ml) with atenolol (50 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (200 ml) with atenolol (50 mg)
Number of subjects: 10
Study: 11942969

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9702617

Group type: EXPERIMENTAL
Intervention: Warmed fluids (setpoint 42 degrees C)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Room temperature fluids (approximately 21 degrees C)
Number of subjects: 61
Study: 8657505

Group type: EXPERIMENTAL
Intervention: Exchange transfusion
Number of subjects: 70

Group type: COMPARATOR
Intervention: Risk factors
Number of subjects: 70
Study: 2400198

Group type: EXPERIMENTAL
Intervention: lacidipine 4 mg b.i.d.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: nifedipine 10 mg b.i.d.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: diltiazem 120 mg b.i.d.
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 367025

Group type: EXPERIMENTAL
Intervention: Subcutaneous low-dose calcium heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous low-dose sodium heparin
Number of subjects: 0
Study: 31916704

Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam) 2 x 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NRL-1 (intranasal diazepam)
Number of subjects: 0
Study: 31034106

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Exercise and cognitive behavioural therapy treatment
Number of subjects: 196
Study: 28697043

Group type: EXPERIMENTAL
Intervention: Oral estradiol (OE) 2 mg/day
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oral estradiol (OE) 2 mg/day + medroxyprogesterone acetate (MPA) 5 mg/day
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 1 mg/day
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 25965710

Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 6068

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6068
Study: 23377899

Group type: EXPERIMENTAL
Intervention: Increased levels of catalytic iron
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Highest quartile of catalytic iron
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Adjusted levels of catalytic iron
Number of subjects: 1701

Group type: COMPARATOR
Intervention: Catalytic iron
Number of subjects: 1701
Study: 21844815

Group type: EXPERIMENTAL
Intervention: Aquacel Ag
Number of subjects: 20

Group type: COMPARATOR
Intervention: Glucan II
Number of subjects: 20
Study: 19264279

Group type: EXPERIMENTAL
Intervention: Listening to music for 1 hour a day for 7 consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 17185126

Group type: EXPERIMENTAL
Intervention: Carbamide peroxide 15%
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 26
Study: 15565569

Group type: EXPERIMENTAL
Intervention: UDCA/MTZ
Number of subjects: 80

Group type: COMPARATOR
Intervention: UDCA/placebo
Number of subjects: 80
Study: 11594949

Group type: EXPERIMENTAL
Intervention: 1% cyclosporine qid
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.2% cidofovir qid
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.2% cidofovir + 1% cyclosporine qid
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sodium chloride qid
Number of subjects: 39
Study: 9781629

Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet
Number of subjects: 61

Group type: COMPARATOR
Intervention: High glycemic index (HGI) diet
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Adipocyte TNF-alpha production
Number of subjects: 61
Study: 8153331

Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 245

Group type: COMPARATOR
Intervention: Ethiodized poppy-seed oil
Number of subjects: 245
Study: 3292711

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, and fluorouracil (CMF)
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, 5-FU, and prednisone (CMFP)
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate, 5-FU, prednisone, and tamoxifen (CMFPT)
Number of subjects: 627

Group type: COMPARATOR
Intervention: Observation (for postmenopausal patients)
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation added to chemotherapy
Number of subjects: 627
Study: 30580488

Group type: EXPERIMENTAL
Intervention: 5-mL syringe
Number of subjects: 200

Group type: COMPARATOR
Intervention: 10-mL syringe
Number of subjects: 200
Study: 28114618

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 1709

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1709

Group type: COMPARATOR
Intervention: Nonenrolled eligible patients (ZES or EES)
Number of subjects: 1709
Study: 25734448

Group type: EXPERIMENTAL
Intervention: Passive chlorinator
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aquatabs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 23798329

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy for patients aged < 50 years
Number of subjects: 2276

Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged ≥ 50 years
Number of subjects: 2276

Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged 50 to 54 years
Number of subjects: 2276

Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged 55 to 59 years
Number of subjects: 2276

Group type: COMPARATOR
Intervention: Intensive chemotherapy for patients aged 60 to 64 years
Number of subjects: 2276
Study: 21672353

Group type: EXPERIMENTAL
Intervention: Intermittent antegrade isothermic blood cardioplegia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antegrade plus continuous retrograde isothermic blood cardioplegia
Number of subjects: 0
Study: 19840568

Group type: EXPERIMENTAL
Intervention: Final ACT >330 seconds
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Final ACT tertiles (lower to upper)
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Final ACT tertiles
Number of subjects: 1234
Study: 16972831

Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (ProSeal LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nasal cannulae (NC)
Number of subjects: 60
Study: 14603549

Group type: EXPERIMENTAL
Intervention: Home-based exercise program consisting of aerobic and strength-building components, performed without direct supervision for six months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual-care group (control)
Number of subjects: 24
Study: 10932443

Group type: EXPERIMENTAL
Intervention: Integrated treatment program for dual disorders (12 months duration)
Number of subjects: 0
Study: 8620097

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1436364

Group type: EXPERIMENTAL
Intervention: Fascia lata
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Periosteum (pericranium)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Fascia of temporalis muscle
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Lyodura (lyophilised cerebral dura mater)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Interrupted sutures
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 69

Group type: COMPARATOR
Intervention: Surgical treatment without dural closure
Number of subjects: 69
Study: 6373685

Group type: EXPERIMENTAL
Intervention: Misonidazole (radiosensitizing drug)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 62
Study: 30043093

Group type: EXPERIMENTAL
Intervention: Timing regimen A (half an hour before breakfast)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Timing regimen B (an hour before the main meal of the day)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Timing regimen C (at bedtime, minimally 2 hours after dinner)
Number of subjects: 84
Study: 26797912

Group type: COMPARATOR
Intervention: Radiographs only
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2-D CT and radiographs
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 3-D CT, 2-D CT and radiographs
Number of subjects: 180
Study: 25643432

Group type: EXPERIMENTAL
Intervention: Low-dose intracoronary UFH (1,000 IU intracoronary UFH)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (70-100 IU/kg intravenous UFH)
Number of subjects: 200
Study: 22608852

Group type: EXPERIMENTAL
Intervention: Minimally invasive midvastus (MMV) approach
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard medial parapatellar (MPP) approach
Number of subjects: 80
Study: 20189026

Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (intermittent arm ischaemia through four cycles of 5‐min inflation and 5‐min deflation of a blood‐pressure cuff)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Control group (without remote conditioning)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Both groups (Remote ischaemic conditioning and Control)
Number of subjects: 333
Study: 18829079

Group type: EXPERIMENTAL
Intervention: New anastomosis technique (single-suture, single-knot, running procedure)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Double running suture (control group)
Number of subjects: 50
Study: 11558045

Group type: EXPERIMENTAL
Intervention: 5 Gy radiotherapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0.5 Gy (placebo dose)
Number of subjects: 31
Study: 10771885

Group type: COMPARATOR
Intervention: Partial exchange transfusion with normal saline
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Partial exchange transfusion with fresh plasma
Number of subjects: 47
Study: 7514356

Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of ketorolac
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 21
Study: 3438618

Group type: EXPERIMENTAL
Intervention: Anticoagulants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31981733

Group type: EXPERIMENTAL
Intervention: ICS/LABA (Mometasone Furoate/Formoterol)
Number of subjects: 8447
Study: 31748208

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma injection
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo injection (dry needle)
Number of subjects: 230
Study: 28894836

Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT) consisting of directive counseling and acoustic enrichment using combination hearing aids and sound generators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care treatment (SC) consisting of general aural rehabilitation counseling and hearing aids
Number of subjects: 0
Study: 25724213

Group type: EXPERIMENTAL
Intervention: Probiotics (1 × 10^9 colony-forming units of Lactobacillus rhamnosus GG and Bifidobacterium infantis per day)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 184
Study: 22930403

Group type: EXPERIMENTAL
Intervention: Curcuminoids (300 mg/day)
Number of subjects: 100
Study: 21810242

Group type: EXPERIMENTAL
Intervention: Task shifting to nurses for prescribing antiretrovirals (ARVs) for uncomplicated patients, combined with integration of HIV care into primary care services.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training and guidelines for nurse ART prescription, local management teams, and implementation toolkit.
Number of subjects: 0
Study: 18339656

Group type: EXPERIMENTAL
Intervention: Damon3 self‐ligating bracket system
Number of subjects: 62

Group type: COMPARATOR
Intervention: Synthesis conventional ligating bracket system
Number of subjects: 62
Study: 17182420

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 0
Study: 12919265

Group type: EXPERIMENTAL
Intervention: Multi-sensory stimulation (MSS)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Activity group (playing card games, looking at photographs, doing quizzes, etc.)
Number of subjects: 136
Study: 11000317

Group type: EXPERIMENTAL
Intervention: RMGIC/CR sandwich restorations
Number of subjects: 118

Group type: COMPARATOR
Intervention: CR restorations
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: RMGIC/CR restorations
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: CR fillings
Number of subjects: 118
Study: 9278875

Group type: EXPERIMENTAL
Intervention: 99mTc-labeled tetrofosmin
Number of subjects: 160

Group type: COMPARATOR
Intervention: 201Tl
Number of subjects: 160
Study: 8466742

Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg once daily) added to nitrendipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg once daily) added to isradipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29930023

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) <120 mm Hg
Number of subjects: 33357

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) ≥160 mm Hg
Number of subjects: 33357

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP) <60 mm Hg
Number of subjects: 33357

Group type: EXPERIMENTAL
Intervention: Pulse Pressure
Number of subjects: 33357

Group type: COMPARATOR
Intervention: Systolic Blood Pressure (SBP) 120-129 mm Hg
Number of subjects: 33357
Study: 27274349

Group type: EXPERIMENTAL
Intervention: Cotton-roll vibration method (a combination of topical anesthesia gel, cotton roll, and vibration for physical distraction)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine topical anesthesia (control)
Number of subjects: 48
Study: 26369799

Group type: EXPERIMENTAL
Intervention: High motivation to quit
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Preference for gradual reduction in cigarettes
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Don't know enjoyment of smoking
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Fewer family or friends who smoke
Number of subjects: 584
Study: 22957829

Group type: EXPERIMENTAL
Intervention: Early response cutoff of 51.6% PANSS total score improvement by week 6
Number of subjects: 132
Study: 21068682

Group type: EXPERIMENTAL
Intervention: GF (glucose + fructose) during SE (strength exercise)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: GF (glucose + fructose) during EE (endurance exercise)
Number of subjects: 20
Study: 18445178

Group type: COMPARATOR
Intervention: Captopril (100 mg) alone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Captopril (100 mg) with low-dose bendroflumethiazide (1.25 mg)
Number of subjects: 15
Study: 17154746

Group type: EXPERIMENTAL
Intervention: Brief psychotherapeutic intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 62
Study: 12592541

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 264

Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 264
Study: 11008903

Group type: EXPERIMENTAL
Intervention: Low levels of nonrecreational physical activity
Number of subjects: 5377

Group type: COMPARATOR
Intervention: Very active men
Number of subjects: 5377

Group type: EXPERIMENTAL
Intervention: Low levels of recreational activity
Number of subjects: 5377

Group type: EXPERIMENTAL
Intervention: Various anthropometric variables
Number of subjects: 5377
Study: 9093546

Group type: EXPERIMENTAL
Intervention: Reduced fat products
Number of subjects: 241

Group type: COMPARATOR
Intervention: Full-fat products
Number of subjects: 241
Study: 8251413

Group type: EXPERIMENTAL
Intervention: Schedule M (intermediate dose methotrexate with folinic acid rescue)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Schedule D (daunorubicin)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Overall remission rate
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Factors predictive of a lower remission rate
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Prognostic factors for those who entered remission
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Time to achieve remission
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Historical comparison with preceding MRC adult trial
Number of subjects: 266
Study: 3895828

Group type: EXPERIMENTAL
Intervention: Routine duration of oral anticoagulation (standard duration)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 50% reduction in duration of oral anticoagulation (reduced duration)
Number of subjects: 80
Study: 31648881

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 111
Study: 30167675

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (10 mg) combined with physical therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo combined with physical therapy
Number of subjects: 64
Study: 27861718

Group type: EXPERIMENTAL
Intervention: Cognitively stimulating activities (daily for up to 30 days)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Cognitively stimulating activities
Number of subjects: 283
Study: 25448081

Group type: EXPERIMENTAL
Intervention: Pathological gambling
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cocaine dependence
Number of subjects: 72

Group type: COMPARATOR
Intervention: Non-addicted group (control)
Number of subjects: 72
Study: 22122590

Group type: EXPERIMENTAL
Intervention: Enhanced adherence support from peer-supporters
Number of subjects: 640

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 640
Study: 20013936

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 411

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Converted from laparoscopic to open surgery
Number of subjects: 411
Study: 27781421

Group type: COMPARATOR
Intervention: Fosdagrocorat 5, 10, or 30 mg (single doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fosdagrocorat 20 mg QD (multiple doses for 12 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (single and multiple doses)
Number of subjects: 30
Study: 16172794

Group type: EXPERIMENTAL
Intervention: Toremifene 60 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12608739

Group type: EXPERIMENTAL
Intervention: Advice to eat more fatty fish
Number of subjects: 452

Group type: COMPARATOR
Intervention: No fish advice (Control)
Number of subjects: 452
Study: 10587476

Group type: EXPERIMENTAL
Intervention: (R)-salbutamol 1.25 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: (RS)-salbutamol 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (S)-salbutamol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (R)-salbutamol and (RS)-salbutamol
Number of subjects: 0
Study: 8735733

Group type: EXPERIMENTAL
Intervention: Stretching of the cervix and stripping of the membranes
Number of subjects: 293

Group type: COMPARATOR
Intervention: Non-stretching/stripping (control group)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Stretching of the cervix and stripping of the membranes (for patients at 41 weeks' gestation or more)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Non-stretching/stripping (control group for patients at 41 weeks' gestation or more)
Number of subjects: 293
Study: 1751787

Group type: EXPERIMENTAL
Intervention: Immunoglobulin G (400 mg/kg body wt)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (normal saline; 8 mL/kg body wt)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Immunoglobulin G
Number of subjects: 40
Study: 7076630

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate withdrawal
Number of subjects: 27

Group type: COMPARATOR
Intervention: Fluphenazine decanoate (continued treatment)
Number of subjects: 27
Study: 31030872

Group type: EXPERIMENTAL
Intervention: Infant Behavior Program (a brief, home‐based adaptation of the child‐directed interaction phase of parent‐child interaction therapy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard pediatric primary care
Number of subjects: 60
Study: 28273891

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (350 mg daily for 24 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 26354287

Group type: EXPERIMENTAL
Intervention: Admitting service (AS) assessment of VTE risk
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prophylaxis ordered based on AS assessment
Number of subjects: 100
Study: 23955487

Group type: EXPERIMENTAL
Intervention: Transcutaneous bilirubin (TcB) measurement at forehead
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Transcutaneous bilirubin (TcB) measurement at abdomen
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Transcutaneous bilirubin (TcB) measurement at sternum
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Transcutaneous bilirubin (TcB) measurement
Number of subjects: 256